$2.23
-0.12-5.11%
近くで: Nov 20, 4:00 PM EST
$2.23
0.00490.22%
時間外: 6:31 PM EST
Sunshine Biopharma (SBFM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-5.20 | $-3.40 | -52.9 % |
| Q2 | Aug 14, 2026 | $-23.00 | $-24.00 | 4.17 % |
| Q1 | May 13, 2026 | $-50.00 | $-32.00 | -56.3 % |
| Q4 | Apr 3, 2026 | $-92.00 | $-54.00 | -70.4 % |
Quarterly Revenue (Billions)
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $9.44M | $9.60M | -1.65 % |
| Q2 | Aug 14, 2026 | $9.26M | $8.60M | 7.72 % |
| Q1 | May 13, 2026 | $8.09M | $9.20M | -12.1 % |
| Q4 | Apr 3, 2026 | $8.58M | $10.00M | -14.2 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-3.40 | $-24.00 | $-32.00 | $-54.00 |
| Actual | $-5.20 | $-23.00 | $-50.00 | $-92.00 |
| Surprise | -52.9% | +4.17% | -56.3% | -70.4% |
| Revenue | ||||
| Estimate | $9.6M | $8.6M | $9.2M | $10.0M |
| Actual | $9.4M | $9.3M | $8.1M | $8.6M |
| Surprise | -1.65% | +7.72% | -12.1% | -14.2% |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-5.80 |
| Revenue | |
| Consensus | $9.8M |
